BMC CANCER Journal

publication venue for

TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. 23. 2023
PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. 22. 2022
Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells. 19. 2019
The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. 19. 2019
A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells. 17. 2017
CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma. 5:141. 2005
Homologous recombination proficiency in ovarian and breast cancer patients 2021
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019 2021
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review 2020

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

1471-2407

Electronic International Standard Serial Number (EISSN)

1471-2407

journal abbreviation

BMC CANCER